ECULIZUMAB
eculizumab 300 mg/30 mL injection, 30 mL vial
ECULIZUMAB (12896R)
12896R
Manner of administration:Injection
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Initial treatment - initial 1 (new patient) induction doses
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Initial treatment - (initial 3) switching from PBS-subsidised pegcetacoplan or iptacopan
for pregnancy (induction doses)
Restriction
Indication: Paroxysmal nocturnal haemoglobinuria (PNH)
Treatment phase: Switching from PBS-subsidised pegcetacoplan or iptacopan - induction doses
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 8 | Max qty units: 8 | # of repeats: 0 | DPMQ: $42,917.68 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Soliris | |||||